NEW YORK, Nov. 13 – Third Wave Technologies has licensed over 3,300 genetic markers from Japan’s Institute of Physical and Chemical Research, the organizations announced Tuesday.

The agreement gives Third Wave Technologies, based in Madison, Wis., the worldwide license, excluding Japan, to research and clinical diagnostic applications to patents for genetic markers within approximately 200 genes related to drug metabolism regulation, according to the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.